The effects of DLEU1 gene expression in Burkitt lymphoma (BL): Potential mechanism of chemoimmunotherapy resistance in BL

• Main Authors: Lee, S, Luo, W, Shah, T, Yin, C, O'Connell, T, Chung, T.-H, Perkins, S.L, Miles, R.R, Ayello, J, Morris, E, Harrison, L, van de Ven, C, Cairo, M.S
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: 2020
• Subjects: cyclophosphamide; rituximab; transcription activator like effector nuclease; animal experiment; animal model; animal tissue; apoptosis; Article; Burkitt lymphoma; cancer chemotherapy; cancer immunotherapy; cancer survival; cell proliferation; controlled study; DLEU1 gene; embryo; female; gene; gene expression; gene overexpression; gene silencing; human; human cell; mouse; nonhuman; tumor xenograft
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179885
• Institution: National University of Singapore

10.18632/oncotarget.15711